Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedDec 21, 2024
DataAggregated Company Financials
Companies11
  • 7D-1.6%
  • 3M-8.5%
  • 1Y16.5%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.6%, driven by AddLife declining 2.6%. This takes the industry's 12 month performance to a gain of 16%. Looking forward, earnings are forecast to grow by 43% annually.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 22 Dec 2024SEK 43.4bSEK 16.7b-SEK 1,152,911,426.0049.7x-37.7x2.6x
Tue, 19 Nov 2024SEK 41.1bSEK 16.8b-SEK 948,072,426.0046.6x-43.3x2.4x
Thu, 17 Oct 2024SEK 47.0bSEK 16.7b-SEK 988,175,491.0056.3x-47.5x2.8x
Sat, 14 Sep 2024SEK 48.8bSEK 16.7b-SEK 988,175,491.0059.1x-49.4x2.9x
Mon, 12 Aug 2024SEK 48.0bSEK 16.7b-SEK 1,128,120,510.0060.1x-42.5x2.9x
Wed, 10 Jul 2024SEK 43.9bSEK 16.3b-SEK 1,188,686,510.0056.8x-36.9x2.7x
Fri, 07 Jun 2024SEK 43.4bSEK 16.3b-SEK 1,188,686,510.0058.9x-36.5x2.7x
Sun, 05 May 2024SEK 39.2bSEK 16.3b-SEK 1,205,235,671.0033.9x-32.5x2.4x
Tue, 02 Apr 2024SEK 40.6bSEK 16.0b-SEK 1,122,792,210.0035.6x-36.2x2.5x
Thu, 29 Feb 2024SEK 38.2bSEK 16.0b-SEK 1,122,868,210.0040.2x-34x2.4x
Sat, 27 Jan 2024SEK 38.4bSEK 15.5b-SEK 1,393,723,683.0047.1x-27.6x2.5x
Mon, 25 Dec 2023SEK 37.2bSEK 15.5b-SEK 1,393,723,683.0044.5x-26.7x2.4x
Wed, 22 Nov 2023SEK 33.0bSEK 15.4b-SEK 1,398,076,683.0036.4x-23.6x2.1x
Fri, 20 Oct 2023SEK 23.2bSEK 15.1b-SEK 1,134,516,711.0032.2x-20.4x1.5x
Sun, 17 Sep 2023SEK 28.3bSEK 15.1b-SEK 1,133,713,072.0038.8x-25x1.9x
Tue, 15 Aug 2023SEK 31.8bSEK 15.1b-SEK 213,871,038.0046.2x-148.5x2.1x
Thu, 13 Jul 2023SEK 35.7bSEK 14.6b-SEK 172,476,038.0036.8x-206.9x2.4x
Sat, 10 Jun 2023SEK 37.9bSEK 14.6b-SEK 172,476,038.0039.9x-219.5x2.6x
Mon, 08 May 2023SEK 39.0bSEK 14.6b-SEK 131,406,792.0036.7x-296.6x2.7x
Wed, 05 Apr 2023SEK 32.9bSEK 14.6b-SEK 57,185,459.0032.6x-575.5x2.3x
Fri, 03 Mar 2023SEK 35.9bSEK 14.6b-SEK 59,119,459.0029.6x-607.9x2.5x
Sun, 29 Jan 2023SEK 39.9bSEK 14.2bSEK 943.9m38.1x42.3x2.8x
Tue, 27 Dec 2022SEK 38.7bSEK 14.1bSEK 944.3m40.6x40.9x2.7x
Thu, 24 Nov 2022SEK 38.1bSEK 14.1bSEK 945.1m41.7x40.4x2.7x
Sat, 22 Oct 2022SEK 34.3bSEK 13.5bSEK 750.9m51.4x45.7x2.5x
Mon, 19 Sep 2022SEK 35.3bSEK 13.5bSEK 750.9m51.9x47.1x2.6x
Wed, 17 Aug 2022SEK 44.4bSEK 13.2bSEK 667.4m46.9x66.6x3.4x
Fri, 15 Jul 2022SEK 44.4bSEK 13.2bSEK 753.4m41.7x59x3.4x
Sun, 12 Jun 2022SEK 51.5bSEK 13.2bSEK 753.4m45.3x68.4x3.9x
Tue, 10 May 2022SEK 46.8bSEK 12.9bSEK 749.4m43.4x62.5x3.6x
Thu, 07 Apr 2022SEK 67.8bSEK 11.8bSEK 745.9m57.2x90.9x5.7x
Sat, 05 Mar 2022SEK 53.0bSEK 11.7bSEK 744.2m44.3x71.3x4.5x
Mon, 31 Jan 2022SEK 61.6bSEK 10.9bSEK 788.9m50.6x78.1x5.6x
Wed, 29 Dec 2021SEK 90.1bSEK 10.8bSEK 786.3m61.9x114.6x8.3x
Price to Earnings Ratio

114.6x


Total Market Cap: SEK 90.1bTotal Earnings: SEK 786.3mTotal Revenue: SEK 10.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average -47.2x202220232024
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 3.0x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
  • Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 16% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market-2.70%
Healthcare0.53%
Life Sciences-1.58%
Clinical Research and Equipment-1.58%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MCAP MedCapSEK 598.000.8%
+SEK 74.0m		75.9%PE38.8x
MAGLE Magle Chemoswed HoldingSEK 34.003.0%
+SEK 18.4m		36.0%PE37.4x
PEXA B PExASEK 0.253.8%
+SEK 524.0k		-42.1%PS18.2x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ALIF B

SEK 136.80

AddLife

7D

-2.6%

1Y

28.2%

AROC

SEK 0.38

AroCell

7D

-3.5%

1Y

-12.7%

MCAP

SEK 598.00

MedCap

7D

0.8%

1Y

75.9%

MAGLE

SEK 34.00

Magle Chemoswed Holding

7D

3.0%

1Y

36.0%

BICO

SEK 32.34

BICO Group

7D

-3.5%

1Y

-46.0%

PRO

SEK 23.80

Promimic

7D

-11.5%

1Y

-31.6%

BIOT

SEK 159.70

Biotage

7D

-1.4%

1Y

22.8%

GENO

SEK 24.95

Genovis AB (publ.)

7D

-0.4%

1Y

-50.3%

PEXA B

SEK 0.25

PExA

7D

3.8%

1Y

-42.1%

ATANA

SEK 0.007

Attana

7D

-66.7%

1Y

-92.5%

LEVBIO

SEK 0.20

Level Bio

7D

-21.6%

1Y

-55.3%